Carole L. Wallis

Analytical Biosciences (China) — China

Medicine · Health Sciences

36h-index4.3kcitations140works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(87), HIV Research and Treatment(82), HIV/AIDS Research and Interventions(81), Pneumocystis jirovecii pneumonia detection and treatment(9), Tuberculosis Research and Epidemiology(8)

Publications139 total

Final 18-month Outcomes of a Trial of Four-Month Rifapentine Regimens With or Without Moxifloxacin for Tuberculosis
SSRN Electronic Journal·2026Open Access
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study
The Lancet HIV·2025· 1 citedOpen Access
A cross‐sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV‐1 in tenofovir disoproxil fumarate‐based pre‐exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa
Journal of the International AIDS Society·2025· 1 citedOpen Access
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Nucleic acid amplification testing using dried blood spots to confirm the diagnosis of HIV-1 in adults
Journal of Clinical Virology·2024Open Access
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries
Clinical Infectious Diseases·2024· 4 citedOpen Access
SARS-CoV-2 Variant is Strongly Associated with Peak Viral Load and Shedding Duration with Minimal Impact from Host Factors: Results from the CoVPN 5001 Study
SSRN Electronic Journal·2024Open Access
Estimation of Background HIV Incidence Using the Recent Infection Testing Algorithm (Rita): Experiences from the Insight HIV Prevention Study in Six Sub-Saharan African Countries
SSRN Electronic Journal·2024Open Access
Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations
Southern African Journal of HIV Medicine·2023· 8 citedOpen Access
Qualification of the differential leukocyte count and immunophenotyping in cryopreserved <i>ex vivo</i> whole blood assay
Cytometry Part A·2023· 1 citedOpen Access
Author response for "Qualification of the differential leukocyte count and immunophenotyping in cryopreserved &lt;i&gt;ex vivo&lt;/i&gt; whole blood assay"
2023
Author response for "Qualification of the differential leukocyte count and immunophenotyping in cryopreserved &lt;i&gt;ex vivo&lt;/i&gt; whole blood assay"
2023
Undiagnosed Pulmonary Tuberculosis (TB) and Coronavirus Disease 2019 (COVID-19) in Adults Dying at Home in a High-TB-Burden Setting, Before and During Pandemic COVID-19: An Autopsy Study
Clinical Infectious Diseases·2023· 7 citedOpen Access
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials
American Journal of Respiratory and Critical Care Medicine·2023· 6 citedOpen Access
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
AIDS Research and Therapy·2023Open Access
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction
Clinical Infectious Diseases·2022· 4 citedOpen Access
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
The Journal of Infectious Diseases·2022· 33 citedOpen Access
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM
Clinical Infectious Diseases·2022· 1 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Wendy Stevens(21), Tobias F. Rinke de Wit(14), Raph L Hamers(13), Kim Sigaloff(10), John W. Mellors(10), Margaret Siwale(8), Rob Schuurman(8), Cissy Kityo(7), Kishor Mandaliya(7), Prudence Ive(7), Akin Osibogun(6), Linda‐Gail Bekker(6), Beatriz Grinsztejn(6), Mariëtte E. Botes(5), Michèle van Vugt(5), François Venter(5), Ian Sanne(5), Catherine Godfrey(5), Mina C. Hosseinipour(5), David Katzenstein(5)